Controllable assembly/disassembly of polyphenol-DNA nanocomplex for cascade-responsive drug release in cancer cells

Jinpeng Han,Yuchen Cui,Zi Gu,Dayong Yang
DOI: https://doi.org/10.1016/j.biomaterials.2021.120846
IF: 14
2021-06-01
Biomaterials
Abstract:Developing nanocarrier systems with sufficient drug loading ability and efficient drug release behavior in cells is a powerful strategy to maximize therapeutic efficacies and minimize side effects of administered drugs. However, the two aspects are usually contradictory in a single nanocarrier. Herein, polyphenol-DNA nanocomplex with controllable assembly/disassembly behaviors is developed for responsive and sequential drug release in cancer cells. Programmable assembly of branched-DNA achieves multiple-gene loading, afterwards tannic acid (TA), plant-derived polyphenols as drugs mediate assembly of branched-DNA to form nanocomplex. Intracellularly, two-step disassembly process of nanocomplex enables efficient gene/drug release. Lysosomal acidic microenvironment induces the disassembly of nanocomplex to release TA and branched-DNA. Glutathione and DNase I in cytoplasm trigger the precise release of genes from branched-DNA. The efficacy of multiple-gene/chemo-therapy is demonstrated using in vitro and in vivo models. This work provides a controllable assembly/disassembly route to resolve the conflict between sufficient drug loading and efficient drug release in cells for therapeutics.
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to develop a nanocarrier system that can simultaneously achieve high drug - loading capacity and efficient intracellular drug release, so as to maximize the therapeutic effect and minimize the side effects of administered drugs. Specifically, the researchers developed a polyphenol - DNA nanocomplex with controllable assembly/disassembly behavior for responsive and sequential drug release in cancer cells. This nanocomplex enables multi - gene loading through programmable branched - DNA self - assembly, and then uses a plant - derived polyphenol, tannic acid (TA), to mediate the assembly of branched - DNA to form a nanocomplex. Intracellularly, the nanocomplex achieves efficient gene/drug release through a two - step disassembly process. - The first step of disassembly occurs in the acidic microenvironment of lysosomes, inducing the nanocomplex to disassemble and release TA and branched - DNA. - The second step of disassembly is triggered by glutathione and DNase I in the cytoplasm, precisely releasing genes. In addition, the paper also verified the efficacy of multi - gene/chemotherapy, in which TA promotes cancer cell apoptosis, antisense DNA inhibits cancer cell proliferation, and DNAzyme inhibits cancer cell migration by down - regulating the expression of MMP - 9 protein. These designs enable the nanocomplex to achieve more controllable drug release intracellularly, thereby resolving the contradiction between drug - loading and release efficiency in traditional nanocarriers.